Sonia Pernas

33PUBLICATIONS
151CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry and metabolomics not elsewhere classifiedMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 15, 2026
Tumor-Infiltrating Lymphocytes as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: Added Value of Morphological Characterization Beyond Quantification.

|May 10, 2026
Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy.

|Dec 03, 2025
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Advanced Breast Cancer: Randomized Phase II, SOLTI-1303 PATRICIA Trial.

Eva Ciruelos, Tomás Pascual, Guillermo Villacampa

|Jun 13, 2025
RETRACTED: Cejuela et al. Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705.

Mónica Cejuela, Begoña Martin-Castillo, Javier A Menendez

|Apr 26, 2025
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.

Helena Pla, Bartomeu Fullana, Anna Esteve

|Jan 11, 2025
Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project).

Eduard Fort-Casamartina, Sonia Pernas, Sara Otero

Pageof 6

Frequent Collaborators

5 joint publications

Miguel Gil-Gil

5 joint publications

Aleix Prat

5 joint publications

Tomás Pascual

4 joint publications

Mónica Cejuela